Crossmark

Serum AKR1B10 predicts the risk of hepatocellular carcinoma – A retrospective single-center study

Crossref DOI link: https://doi.org/10.1016/j.gastre.2019.06.003

Published Print: 2019-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Zhu, Rongping

Xiao, Juan

Luo, Diteng

Dong, Mingjun

Sun, Tian

Jin, Junfei
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81360309, 81572738)

Natural Science Foundation of Guangxi (2015GXNSFEA139003)

“Sphingolipids and Related Diseases”

“the Introduction of Overseas High-Level Talents in Colleges and Universities in Guangxi”

High Level of Innovation Team and Outstanding Scholars Program
License Information

Text and Data Mining valid from 2019-12-01
More Information

This article is maintained by: Elsevier

Article Title: Serum AKR1B10 predicts the risk of hepatocellular carcinoma – A retrospective single-center study

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2019.06.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2019.06.007

Content Type: article

Copyright: © 2019 Elsevier España, S.L.U. All rights reserved.